Evidence map›Paper›PMID 29309418›Full record

ArticlePloS one2018

Emergence as an outbreak of the HIV-1 CRF19_cpx variant in treatment-naïve patients in southern Spain.

Carmen M González-Domenech, Isabel Viciana, Luis Delaye, María Luisa Mayorga, Rosario Palacios, Javier de la Torre, Francisco Jarilla, Manuel Castaño, Alfonso Del Arco, Encarnación Clavijo and 1 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.2field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 14 citations in OpenAlex.

  1. Observational
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Observational
  8. Article
  9. Article
  10. Genome-scale analysis of evolutionary rate and selection in a fast-expanding Spanish cluster of HIV-1 subtype F1.Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 2 countries.

Carmen M González-DomenechBiomedical Research Institute of Malaga (IBIMA), Málaga, Spain.ORCID 0000-0001-8248-3904
Isabel VicianaBiomedical Research Institute of Malaga (IBIMA), Málaga, Spain.
Luis DelayeDepartamento de Ingeniería Genética, CINVESTAV. Guanajuato, Irapuato, México.
María Luisa MayorgaInfectious Diseases and Clinical Microbiology Unit, Carlos Haya Regional Hospital, Málaga, Spain.
Rosario PalaciosBiomedical Research Institute of Malaga (IBIMA), Málaga, Spain.
Javier de la TorreInfectious Diseases Unit, Service of Internal Medicine, Costa del Sol Hospital, Marbella, Spain.
Francisco JarillaService of Internal Medicine, Antequera Local Hospital, Málaga, Spain.
Manuel CastañoInfectious Diseases and Clinical Microbiology Unit, Carlos Haya Regional Hospital, Málaga, Spain.
Alfonso Del ArcoInfectious Diseases Unit, Service of Internal Medicine, Costa del Sol Hospital, Marbella, Spain.
Encarnación ClavijoInfectious Diseases and Clinical Microbiology Unit, Virgen de la Victoria Hospital, Málaga, Spain.
Jesús SantosBiomedical Research Institute of Malaga (IBIMA), Málaga, Spain.
Hospital Clínico Universitario Virgen de la Victoria · ESHospital Regional Universitario de Málaga · ESHospital Costa del Sol · ESCentro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional · MXInstituto de Investigación Biomédica de Málaga · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCRF19_cpx is a complex circulating recombination form (CRF) of HIV-1. We describe the characteristics of an outbreak of the CRF19_cpx variant among treatment-naïve patients in southern Spain.

methodsThe study was undertaken at the Virgen de la Victoria Hospital, a reference centre for the analysis of HIV-1 genotype in Malaga (Spain). Subtyping was performed through REGA v3.0 and the relationship of our CRF19_cpx sequences, among themselves and regarding other reference sequences from the same variant, was defined by phylogenetic analysis. We used PhyML program to perform a reconstruction of the phylogeny by Maximum Likelihood method as well as further confirmation of the transmission clusters by Bayesian inference. Additionally, we collected demographic, clinical and immunovirological data.

resultsBetween 2011 and 2016, we detected 57 treatment-naïve patients with the CRF19_cpx variant. Of these, 55 conformed a very well-defined transmission cluster, phylogenetically close to CRF19_cpx sequences from the United Kingdom. The origin of this subtype in Malaga was dated between 2007 and 2010. Over 50% of the patients presented the non-nucleoside reverse transcriptase inhibitor G190A resistance mutation. This variant was mostly represented by young adult Spanish men who had sex with men. Almost half of them were recent seroconverters, though a similar percentage was diagnosed at a late state of HIV infection. Five cases of AIDS and one non-AIDS defined death occurred during follow-up. The majority of patients treated with first-line combination antiretroviral therapy (ART) responded.

conclusionsWe report the largest HIV-1 CRF19_cpx cohort of treatment-naïve patients outside Cuba, almost all emerging as an outbreak in the South of Spain. Half the cases had the G190A resistance mutation. Unlike previous studies, the variant from Malaga seems less pathogenic, with few AIDS events and an excellent response to ART.

Indexed as

Disease OutbreaksAdultBayes TheoremCD4 Lymphocyte CountCohort StudiesFemaleGenotypeHIV-1HIV InfectionsHumansMalePhylogenySpainViral LoadYoung Adult

Identifiers

PMID29309418
PMCPMC5757947
OpenAlexW2783950492

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.